Everest Organics Ltd.

NSE: EVERESTO | BSE: 524790 | ISIN: INE334C01029 | Industry: Pharmaceuticals
| Momentum Trap
330.0000 3.00 (0.92%)
BSE Jul 14, 2025 15:31 PM
Volume: 1,936
 

The US FDA completed an inspection of the Everest Organics facility in Arooor vilalge, between the 27th of Feb and the 3rd of March. The inspection resulted in one observation from the FDA, which Everest says is minor in nature, and "will address with corrective action".

Promoters have decreased holdings from 74.15% to 61.09% in Mar 2025 qtr
More from Everest Organics Ltd.
Recommended